Clinical trial
Autologous Stem Cell Transplants for Chronic Myelogenous Leukemia
NCT00446173 · M.D. Anderson Cancer Center, Other · Withdrawn
Key facts
| NCT number | NCT00446173 |
|---|---|
| Title | Autologous Stem Cell Transplants for Chronic Myelogenous Leukemia |
| Official title | Autologous Purged Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia (CML) |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Drug |
| Interventions | Busulfan, Cyclophosphamide, G-CSF, GM-CSF |
| Enrollment | 0 |
| Start date | Mar 1, 2007 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Mar 12, 2007 |
| Last update posted | Aug 25, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: